Low vitamin D and a large waistline may each be risky on their own, and together they appear considerably more dangerous.
Researchers in Brazil with University College London followed 5,520 adults aged 50 and older for six years, using the English Longitudinal Study of Ageing. People with both abdominal obesity and vitamin D deficiency (below 30 nmol/L) had a 123% higher risk of death than those with neither. Individually, abdominal obesity was linked to 47% higher risk and vitamin D deficiency to up to 91%. The study appeared in Diabetes, Obesity and Metabolism.
Why abdominal fat specifically
The distinction between abdominal obesity and general obesity is not cosmetic, and it explains why waist measurement is used rather than body mass index.
Fat stored around the abdomen — particularly visceral fat surrounding the organs — is metabolically different from fat under the skin. It is more inflammatory, releases fatty acids directly into the portal circulation feeding the liver, and is more strongly associated with insulin resistance, cardiovascular disease and mortality.
Two people with the same BMI can have very different amounts of visceral fat, which is why waist-based measures frequently predict outcomes better than weight alone.
The proposed interaction
The researchers point to a biological link: abdominal fat sequesters vitamin D inside fat cells, lowering how much is available in the bloodstream, while also impairing vitamin D metabolism.
The mechanism is plausible and well described. Vitamin D is fat-soluble, so it distributes into adipose tissue, and people with more body fat have a larger compartment for it to disperse into — producing lower blood levels at the same intake or sun exposure.
“When these two conditions occur together, one amplifies the effects of the other, further increasing the risk of death,” said researcher Tiago Silva Alexandre.
The direction problem this creates
That mechanism, while explaining the association, also undermines the causal interpretation — and this is the study’s central interpretive difficulty.
If abdominal fat lowers measured vitamin D by sequestering it, then low vitamin D in obese people is partly a consequence of the obesity rather than an independent problem. The person may have adequate total body vitamin D distributed across a larger volume, with the blood measurement reading low for reasons of dilution rather than deficiency.
On that reading, low vitamin D would be a marker of adiposity rather than an additional risk factor — and treating it with supplements would not address anything.
Why supplement trials have disappointed
This matters because the obvious response to a deficiency finding is supplementation, and large randomised trials of vitamin D supplementation have generally failed to show the benefits observational studies predicted.
Trials examining cardiovascular events, cancer, fractures and mortality have mostly been null or marginal, despite consistent observational associations between low vitamin D and worse outcomes across all of them.
The leading explanation for that gap is precisely the one relevant here: low vitamin D may be a marker of poor health — less time outdoors, less physical activity, more chronic illness, more adiposity — rather than a cause of it. Correcting the measurement does not correct what it was indicating.
The confounding beyond that
The study is observational, so it shows association rather than causation, and people with both conditions differ in other ways.
Low vitamin D correlates with limited sun exposure, which correlates with reduced mobility, indoor confinement and chronic illness. Abdominal obesity correlates with diet, activity, socioeconomic position and multiple diagnosed conditions. Someone with both is likely to be less healthy in numerous unmeasured respects.
What the interaction finding still contributes
Even discounted, the result is worth noting for one reason: the combined risk of 123% exceeds what simply adding the individual risks would produce, which is what makes it an interaction rather than two separate effects.
That pattern is consistent with the two conditions genuinely amplifying one another, and it identifies a subgroup at particularly elevated risk — useful for identifying who warrants closer attention, regardless of whether either factor is causal.
What to do with it
It reinforces attention to two modifiable factors, and the appropriate response is not self-supplementation.
What the supplement trials actually tested
Since the obvious response to a deficiency finding is supplementation, it is worth being precise about what the large trials examined and where they leave room.
The major randomised studies enrolled largely unselected adult populations, most of whom had adequate or near-adequate vitamin D at baseline, and gave supplements for several years measuring cardiovascular events, cancer and mortality. Results were essentially null.
Critics have pointed out that testing supplementation in people who are not deficient is a poor test of whether correcting deficiency helps — analogous to testing iron supplements in people without anaemia. Subgroup analyses restricted to those with genuinely low baseline levels have sometimes suggested benefit, though such analyses carry the usual limitations.
So the honest position is narrower than either camp claims. Supplementation across a general population does not appear to reduce major outcomes; whether it helps people who are genuinely deficient, particularly those with obesity where the deficiency may be partly apparent rather than real, remains inadequately tested.
Anyone concerned about vitamin D or waist size should talk with a clinician rather than acting on a single study — particularly given that the evidence for supplementation changing outcomes remains weak while the evidence for reducing visceral fat is considerably stronger. This summarises an observational study and is not medical advice. Talk to a healthcare professional about vitamin D testing, supplements, or weight management.